ARZEDA Corp.

Seattle, WA · CIK 0001712438 · Defense · Private

Computationally designed enzymes based on human PON1 scaffold for deactivating chemical warfare nerve agents

arzeda.com →
Grants
$2.7M
4 awards
Sector median: 2
Raised
$60M
6 Form D · Sep 2025
13 months since last filing
Contracts
—
No federal contracts on record
Patents
34
4 granted · 30 pending
Sector median: 0

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Agriculture · Production Of Methyl-ethyl-ketone (mek) From Renewable Feedstock$90,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II: A computational and experimental platform for the automated design of organisms used in the production of biochemicals$1,260,814
Federal grantDepartment of Energy · Phase I · Synthetic Transcription Factors: Detecting and Increasing the Production of Next Generation Bio-Based Chemicals and Fuels$224,947
Private capital raisedForm D · SEC$10,499,985
Private capital raisedForm D · SEC$1,000,000
Private capital raisedForm D · SEC$3,250,000
Private capital raisedForm D · SEC$25,732,378
Federal grantDepartment of Defense · Phase II · Designer Protein Therapeutics as Medical Countermeasures Against Organophosphate Chemical Warfare Agents: Evaluation and Optimization of Lead Computationally Designed Non-Immunogenic Enzymes$1,118,433
Private capital raisedForm D · SEC$14,935,945
Private capital raisedForm D · SEC$4,511,776
Federal grant · SBIR/STTRForm D · SEC

Peer position

Defense · 1442 companies · ranked on federal contract value
Defense companies ranked by federal contract value
#CompanyContractsDisclosed equity
1387LIDOMIKA LLC——
1388F9 Teams Inc.—$325K
1389TENACITY SPACE SYSTEMS, INC.——
1390ARZEDA Corp.—$60M
1391SensorSurf——
1392CRUSOE SURVIVAL, LLC——
1393Wavefront—$38M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 14 related persons
  • Eric AlthoffDirector · Executive Officer · Promoter
  • Andrew BanExecutive Officer
  • Bill BaumDirector
  • William BaumDirector
  • Doug CameronDirector
  • Yanniv DoroneDirector
  • Daniela GrabsDirector · Executive Officer · Promoter
  • Jeff KlunzingerDirector
  • Jeffrey KlunzingerDirector
  • Nanda Kumar R PuthucodeDirector
  • Brian LoebDirector
  • Larry PageDirector
  • Sanjay PalExecutive Officer
  • Alexandre ZanghelliniDirector · Executive Officer · Promoter

Patents

USPTO · 4 granted of 34

Regulatory activity · Defense

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.